IMFINZI conc perf 120 mg/2.4ml flac 2.4 ml
7680665480015
CH-66548
L01FF03
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6654801
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- durvalumabum 120 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2.4 ml.
Articles (1)
Imfinzi 120 mg/2.4 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
durvalumabum
|
120.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 515.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2018
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 66548
- Drug name
- Imfinzi, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FF03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 11/06/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IMFINZI conc perf 120 mg/2.4ml flac 2.4 ml
- Description (DE)
- IMFINZI Inf Konz 120 mg/2.4ml Durchstf 2.4 ml
- Market launch
- 11/06/2018
- Narcotic (BTM)
- No